This Smart Home Stock Just Drew a $42 Million Institutional Bet — Should Long-Term Investors Follow? Despite a recent pullback, shares are still up big over the past year, and one investor seems to be expecting further upside.
Millrose Stock Up 40% Since Spin-Off — So Why Did One Fund Just Sell 1 Million Shares? After a sharp post-spin rally, one investor’s trim raises a question about how Millrose fits into long-term housing capital strategies.
Why a Fund Has a $194 Million TIC Solutions Bet Despite a 20% Drop Since Its NYSE Listing A recent portfolio move highlights why scale, recurring revenue, and integration execution may matter more than short-term stock swings.
This Stock Is Down 40% From Its Peak, So Why Is One Fund Betting $150 Million on It? With shares well off their highs, one fund is leaning into fundamentals that the market may be overlooking.
GRIFOLS SA-ADR (NASDAQ:GRFS) Screens as High-Growth Momentum Stock with Strong Technicals Grifols (GRFS) stock shows strong technical momentum and explosive earnings growth, fitting a high-growth trend template for potential market leaders.
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday? Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial stability in 2024.
Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols Brookfield Asset Management is reportedly pursuing €9.5 billion in debt financing for a potential take-private deal for Grifols. The deal could lead to major financial restructuring, impacting bondholders and shareholders amid scrutiny of Grifols' high debt levels and credit downgrades.
3 Stocks to Buy From the ‘Ultimate’ Buy-and-Hold Portfolio Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro.
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares.
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why Grifols reveals Brookfield Capital's preliminary discussions with major shareholders about a potential joint bid to delist the company from Spanish stock exchanges and NASDAQ. An exclusivity agreement has been signed, and due diligence is underway, with the deal estimated at 5.5 billion euros.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to know about on Monday!
